Korea Investment Corp
MRNA icon

Korea Investment Corp’s Moderna MRNA Stock Holding History

Korea Investment Corp’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-167,547
Closed -$4.75M – 717
2025
Q1 		$4.75M Buy
167,547
+13,000
+8% +$461K 0.01% 622
2024
Q4 		$6.43M Sell
154,547
-8,189
-5% -$391K 0.02% 591
2024
Q3 		$10.9M Sell
162,736
-110,762
-40% -$10.2M 0.03% 472
2024
Q2 		$32.5M Buy
273,498
+9,022
+3% +$1.14M 0.08% 229
2024
Q1 		$28.2M Buy
264,476
+9,401
+4% +$948K 0.07% 275
2023
Q4 		$25.4M Sell
255,075
-24,525
-9% -$2.06M 0.07% 277
2023
Q3 		$28.9M Sell
279,600
-48,750
-15% -$5.44M 0.09% 247
2023
Q2 		$39.9M Buy
328,350
+54,421
+20% +$7.26M 0.11% 207
2023
Q1 		$42.1M Sell
273,929
-48,210
-15% -$7.95M 0.12% 193
2022
Q4 		$57.9M Buy
322,139
+28,290
+10% +$4.63M 0.18% 136
2022
Q3 		$34.7M Buy
293,849
+49,796
+20% +$7.56M 0.11% 211
2022
Q2 		$34.9M Sell
244,053
-2,047
-0.8% -$293K 0.11% 220
2022
Q1 		$42.4M Sell
246,100
-55,100
-18% -$9.28M 0.1% 213
2021
Q4 		$76.5M Buy
301,200
+171,300
+132% +$50.1M 0.2% 131
2021
Q3 		$50M Sell
129,900
-38,800
-23% -$14.3M 0.15% 167
2021
Q2 		$39.6M Buy
168,700
+78,100
+86% +$14M 0.11% 194
2021
Q1 		$11.9M Sell
90,600
-15,800
-15% -$2.29M 0.04% 339
2020
Q4 		$11.1M Buy
106,400
+27,400
+35% +$2.77M 0.03% 342
2020
Q3 		$5.59M Buy
79,000
+7,300
+10% +$509K 0.02% 413
2020
Q2 		$4.6M Buy
+71,700
New +$3.93M 0.02% 445

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Korea Investment Corp's MRNA Position: Q2 2025 in Review

Korea Investment Corp sold out of Moderna (MRNA) in Q2 2025, closing a stake of 167,547 shares — an estimated $4.75M sold.

Korea Investment Corp first reported a position in MRNA in Q2 2020 and held it in 20 quarters. The position peaked at $76.5M in Q4 2021. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Korea Investment Corp reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Korea Investment Corp sold 167,547 Moderna shares in Q2 2025, an estimated $4.75M.
  • Korea Investment Corp first reported a position in Moderna in Q2 2020 and held it in 20 quarters.
  • Korea Investment Corp's Moderna position peaked at $76.5M in Q4 2021.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Korea Investment Corp's 13F filing for Q2 2025, filed 13 Aug 2025.